Diabetes management in an Australian primary care population

What is known and objective:  Worldwide studies have shown that significant proportions of patients with type 2 diabetes (T2DM) do not meet targets for glycaemic control, blood pressure (BP) and lipids, putting them at higher risk of developing complications. However, little is known about medicines management in Australian primary care populations with T2DM. The aim of this study was to (i) describe the management of a large group of patients in primary care, (ii) identify areas for improvement in management and (iii) determine any relationship between adherence and glycaemic, BP and lipid control.

[1]  J. Remon,et al.  Medication use and disease management of type 2 diabetes in Belgium. , 2008, Pharmacy World & Science.

[2]  J. Remon,et al.  Medication use and disease management of type 2 diabetic flemish patients , 2007, Pharmacy World & Science.

[3]  K. Dodd,et al.  Guideline implementation in allied health professions: a systematic review of the literature , 2008, Quality & Safety in Health Care.

[4]  Executive Summary: Standards of Medical Care in Diabetes—2010 , 2010, Diabetes Care.

[5]  J. Cramer.  A systematic review of adherence with medications for diabetes. , 2004, Diabetes care.

[6]  D. Chisholm,et al.  Diabetes guidelines : easier to preach than to practise ? , 2006 .

[7]  D. Matthews,et al.  Poor glycaemic control in type 2 diabetes: a conspiracy of disease, suboptimal therapy and attitude. , 2000, QJM : monthly journal of the Association of Physicians.

[8]  C. Cooke,et al.  Physician conformity and patient adherence to ACE inhibitors and ARBs in patients with diabetes, with and without renal disease and hypertension, in a medicaid managed care organization. , 2015, Journal of managed care pharmacy : JMCP.

[9]  E. Blaak,et al.  Lifestyle intervention for prevention of diabetes: determinants of success for future implementation. , 2009, Nutrition reviews.

[10]  J M Grimshaw,et al.  Effectiveness and efficiency of guideline dissemination and implementation strategies , 2004, International Journal of Technology Assessment in Health Care.

[11]  Alexandria,et al.  Recommendations for Evaluating Compliance and Persistence With Hypertension Therapy Using Retrospective Data , 2006, Hypertension.

[12]  Richard W Grant,et al.  How Doctors Choose Medications to Treat Type 2 Diabetes , 2007, Diabetes Care.

[13]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[14]  Challenges in diabetes management. , 2008, Australian family physician.

[15]  K. Blumenschein,et al.  Outcomes from DiabetesCARE: a pharmacist-provided diabetes management service. , 2008, Journal of the American Pharmacists Association : JAPhA.

[16]  Management of dyslipidaemia in patients with type 2 diabetes in Australian primary care , 2007, The Medical journal of Australia.

[17]  S. Prato.  Megatrials in type 2 diabetes. From excitement to frustration? , 2009, Diabetologia.

[18]  G. R. Weitoft,et al.  Refill adherence to oral antihyperglycaemic drugs in Sweden , 2009, Acta Diabetologica.

[19]  Richard Barnett.  Diabetes , 1904, The Lancet.

[20]  I. Krass,et al.  Impact on medication use and adherence of Australian pharmacists' diabetes care services. , 2005, Journal of the American Pharmacists Association : JAPhA.

[21]  K. Hermansen,et al.  Combining insulins with oral antidiabetic agents: effect on hyperglycemic control, markers of cardiovascular risk and disease , 2008, Vascular health and risk management.

[22]  R. Ratner,et al.  Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey. , 2006, Diabetes care.

[23]  M. Langford.  Type 2 Diabetes and Chronic Systolic Heart Failure: Clinical Implications , 2004, The Journal of cardiovascular nursing.

[24]  J. Shaw,et al.  Glucose, lipid, and blood pressure control in Australian adults with type 2 diabetes: the 1999-2000 AusDiab. , 2005, Diabetes care.

[25]  Lisa Dolovich,et al.  GPs' approach to insulin prescribing in older patients: a qualitative study. , 2008, The British journal of general practice : the journal of the Royal College of General Practitioners.

[26]  J. Paladino,et al.  Clinical and economic impact of a diabetes clinical pharmacy service program in a university and primary care-based collaboration model. , 2009, Journal of the American Pharmacists Association : JAPhA.